Genetic disruption of the SH2B1 gene results in severe leptin resistance, insulin resistance, obesity, type 2 diabetes, and NAFLD in mice [25], [26]. This evidence concerns the gene SH2B1 and metabolic dysfunction-associated steatotic liver disease.